BenzingaSeptember 11, 2026 at 6:11 AM NYLast Month
UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
